Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.

The cloning of cytokine cDNAs has permitted the analysis of cytokine expression in diseased sites such as rheumatoid joints. A very wide range of cytokines were detected, mostly with proinflammatory activities. From the analysis of cytokine regulation in rheumatoid joint cell cultures using neutrali...

Bibliografske podrobnosti
Main Authors:	Feldmann, M, Brennan, F, Williams, R, Elliott, M, Maini, R
Format:	Journal article
Jezik:	English
Izdano:	1995

Podobne knjige/članki

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
od: Elliott, M, et al.
Izdano: (1995)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1994)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
od: Elliott, M, et al.
Izdano: (1995)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
od: Maini, R, et al.
Izdano: (1993)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1994)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
od: Brennan, F, et al.
Izdano: (1992)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, et al.
Izdano: (1995)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
od: Feldmann, M, et al.
Izdano: (1994)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2001)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
od: Feldmann, M, et al.
Izdano: (2011)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
od: Brennan, F, et al.
Izdano: (1989)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
od: Maini, R, et al.
Izdano: (1997)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
od: Feldmann, M, et al.
Izdano: (2001)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
od: Maini, R, et al.
Izdano: (1995)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
od: Charles, P, et al.
Izdano: (1999)

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
od: Butler, D, et al.
Izdano: (1995)

Role of cytokines in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1996)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1994)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
od: Feldmann, M
Izdano: (1996)

TNFα - A pivotal role in rheumatoid arthritis?
od: Brennan, F, et al.
Izdano: (1992)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
od: Feldmann, M, et al.
Izdano: (1997)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
od: Feldmann, M, et al.
Izdano: (2002)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
od: Taylor, P, et al.
Izdano: (2000)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
od: Brennan, F, et al.
Izdano: (1998)

Cytokine expression in rheumatoid arthritis.
od: Brennan, F, et al.
Izdano: (1991)

Cytokine therapy in rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1996)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1997)

Cytokine blockade in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2001)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
od: Feldman, M, et al.
Izdano: (1998)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
od: Paleolog, E, et al.
Izdano: (1996)

The role of cytokines in the pathogenesis of rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1999)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
od: Williams, R, et al.
Izdano: (2000)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
od: Feldmann, M
Izdano: (1996)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
od: Maini, R, et al.
Izdano: (2000)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
od: Maini, R, et al.
Izdano: (1998)

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
od: Cope, A, et al.
Izdano: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
od: Elliott, M, et al.
Izdano: (1993)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2004)